![Uma Sinha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uma Sinha
Directeur Technique/Scientifique/R&D chez
EIDOS THERAPEUTICS, INC.
Fortune : 54 900 $ au 31/05/2026
Profil
Actuellement, Uma Sinha occupe le poste de directeur scientifique de BridgeBio Pharma, Inc. et celui de directeur scientifique d'Eidos Therapeutics, Inc. (une filiale de BridgeBio Pharma, Inc.). Auparavant, le Dr Sinha a occupé le poste de directeur scientifique de Global Blood Therapeutics, Inc, de directeur principal de COR Therapeutics, Inc, de directeur principal du secteur cardiovasculaire de Millennium Pharmaceuticals, Inc, de directeur principal de Genencor International, Inc et de vice-président et chef de la biologie de Portola Pharmaceuticals, Inc. Elle a obtenu un doctorat de l'université de Géorgie et un diplôme de premier cycle du Presidency College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/05/2026 | 30 000 ( 0,02% ) | 54 900 $ | 31/05/2026 |
Postes actifs de Uma Sinha
| Sociétés | Poste | Début |
|---|---|---|
| EIDOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2016 |
| BRIDGEBIO PHARMA, INC. | Directeur Technique/Scientifique/R&D | 01/04/2016 |
| PROKIDNEY CORP. | Directeur/Membre du Conseil | 01/07/2022 |
Anciens postes connus de Uma Sinha
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2015 |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2012 |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Corporate Officer/Principal | 01/01/2002 |
| PROKIDNEY A | Directeur/Membre du Conseil | - |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Corporate Officer/Principal | - |
Formation de Uma Sinha
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Presidency College
 Presidency College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Social Capital Suvretta Holdings Corp. III
 Social Capital Suvretta Holdings Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
ProKidney Corp.
 ProKidney Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
